Platelet activating factor (PAF) and activity of its biosynthetic and catabolic enzymes in blood and leukocytes of male patients with newly diagnosed heart failure.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Clinical Biochemistry

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.clinbiochem.2008.09.113PMID 18955040
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Serum uric acid levels correlate with left atrial function and systolic right ventricular function in patients with newly diagnosed heart failure: the hellenic heart failure study.

  2008cited by this paper
• Effects of a low-calorie diet associated with weight loss on lipoprotein-associated phospholipase A2 (Lp-PLA2) activity in healthy obese women.

  2008cited by this paper
• Relationship between CD40 ligand expression and B type natriuretic peptide levels in patients with chronic heart failure.

  2008cited by this paper
• Lipoprotein-associated phospholipase A2 activity and risk of heart failure: The Rotterdam study

  2007cited by this paper
• Role of inflammation in the progression of heart failure

  2007cited by this paper
• The Proangiogenic Phenotype of Tumor-Derived Endothelial Cells is Reverted by the Overexpression of Platelet-Activating Factor Acetylhydrolase

  2007cited by this paper
• New Insights Into the Role of Lipoprotein(a)-Associated Lipoprotein-Associated Phospholipase A2 in Atherosclerosis and Cardiovascular Disease

  2007cited by this paper
• Characterization of the De Novo Biosynthetic Enzyme of Platelet Activating Factor, DDT-Insensitive Cholinephosphotransferase, of Human Mesangial Cells

  2007cited by this paper
• Role of lipoprotein-associated phospholipase A2 in leukocyte activation and inflammatory responses.

  2007cited by this paper
• Effect of spironolactone on C-reactive protein levels in patients with heart disease.

  2007cited by this paper
• Relationship of soluble CD40 ligand to vascular endothelial growth factor, angiopoietins, and tissue factor in atrial fibrillation: a link among platelet activation, angiogenesis, and thrombosis?

  2007cited by this paper
• Soluble CD40 ligand in acute and chronic heart failure.

  2005cited by this paper
• Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.

  2005cited by this paper
• Anti-inflammatory therapy for heart failure.

  2004cited by this paper
• Platelet activating factor — a molecular link between atherosclerosis theories

  2003cited by this paper
• Platelet-Activating Factor Mediates CD40-Dependent Angiogenesis and Endothelial-Smooth Muscle Cell Interaction 1

  2003cited by this paper
• Platelet-Activating Factor, a Pleiotrophic Mediator of Physiological and Pathological Processes

  2003cited by this paper
• Heart failure.

  2003cited by this paper
• Acetyl-CoA:1-O-alkyl-sn-glycero-3-phosphocholine acetyltransferase (lyso-PAF AT) activity in cortical and medullary human renal tissue.

  2003cited by this paper
• Furosemide: Progress in Understanding Its Diuretic, Anti-inflammatory, and Bronchodilating Mechanism of Action, and Use in the Treatment of Respiratory Tract Diseases

  2002cited by this paper
• Altered distribution of platelet-activating factor- acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolemia.

  2002cited by this paper
• Regulation of platelet-activating factor synthesis in human neutrophils by MAP kinases.

  2002cited by this paper
• Expression of CD154 on renal cell carcinomas and effect on cell proliferation, motility and platelet‐activating factor synthesis

  2002cited by this paper
• Regulation of VEGF‐induced endothelial cell PAF synthesis: role of p42/44 MAPK, p38 MAPK and PI3K pathways

  2001cited by this paper
• Role of platelet-activating factor in cardiovascular pathophysiology.

  2000cited by this paper
• Elevated soluble CD14 receptors and altered cytokines in chronic heart failure.

  1997cited by this paper
• Lyso-PAF acetyltransferase activity in neutrophils of patients during acute asthma and after recovery

  1996cited by this paper
• Lyso-PAF acetyltransferase activity in neutrophils of patients during acute asthma and after recovery.

  1996cited by this paper
• Platelet‐activating factor and arachidonic acid metabolites in psoriatic inflammation

  1996cited by this paper
• Platelet-activating factor and its analogs: metabolic pathways and related intracellular processes.

  1995cited by this paper
• A simple and precise method for the routine determination of platelet-activating factor in blood and urine

  1994cited by this paper
• Nitrovasodilators inhibit thrombin-induced platelet-activating factor synthesis in human endothelial cells.

  1992cited by this paper
• Synthesis of platelet-activating factor by polymorphonuclear neutrophils stimulated with interleukin-8.

  1992cited by this paper
• Calcium channel blockade inhibits platelet activating factor production by human umbilical vein endothelial cells

  1991cited by this paper
• Atherosclerosis and Cardiovascular Disease

  1990cited by this paper
• Selected cytokines promote the synthesis of platelet-activating factor in vascular endothelial cells: comparison between tumor necrosis factor alpha and beta and interleukin-1.

  1990cited by this paper
• Inhibition of lyso-PAF: acetyl-CoA acetyltransferase by salicylates and other compounds.

  1988cited by this paper
• Biosynthesis of platelet-activating factor in human polymorphonuclear leukocytes. Involvement of the cholinephosphotransferase pathway in response to the phorbol esters.

  1988cited by this paper
• Biphasic platelet-activating factor synthesis by human monocytes stimulated with IL-1-beta, tumor necrosis factor, or IFN-gamma.

  1988cited by this paper
• Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor.

  1987cited by this paper
• Effect of C-reactive protein on platelet-activating factor-induced platelet aggregation and membrane stabilization.

  1985cited by this paper
• Increased biosynthesis of platelet-activating factor in activated human eosinophils.

  1984cited by this paper
• Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators).

  1979influential reference
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• A rapid method of total lipid extraction and purification.

  1959cited by this paper
• Heart Failure

  1937cited by this paper

• Effect of moderate wine consumption on the activity of enzymes involved in platelet-activating factor metabolism and thrombotic biomarkers: a randomised, single-blind, parallel, clinical study in CHD men patients

  2025cites this paper
• Role of long noncoding RNAs in pathological cardiac remodeling after myocardial infarction: An emerging insight into molecular mechanisms and therapeutic potential.

  2024cites this paper
• Role of Platelet-Activating Factor in the Pathogenesis of Chronic Spontaneous Urticaria

  2024cites this paper
• Associations of phase angle with platelet-activating factor metabolism and related dietary factors in healthy volunteers

  2023cites this paper
• Mediterranean Diet and Sarcopenia Features in Apparently Healthy Adults over 65 Years: A Systematic Review

  2023cites this paper
• Relation of Mean Platelet Volume (MPV) with Cancer: A Systematic Review with a Focus on Disease Outcome on Twelve Types of Cancer

  2023cites this paper
• Nutritional Risk and Sarcopenia Features in Patients with Crohn’s Disease: Relation to Body Composition, Physical Performance, Nutritional Questionnaires and Biomarkers

  2023cites this paper
• The association between dietary quality scores with C-reactive protein and novel biomarkers of inflammation platelet-activating factor and lipoprotein-associated phospholipase A2: a cross-sectional study

  2023cites this paper
• Postprandial Metabolic and Oxidative Stress Responses to Grape Pomace Extract in Healthy Normal and Overweight/Obese Women: A Randomized, Double-Blind, Placebo-Controlled Crossover Study

  2022cites this paper
• Critical role of PAFR/YAP1 positive feedback loop in cardiac fibrosis

  2022cites this paper
• Consumption of Farmed Fish, Fed with an Olive-Pomace Enriched Diet, and Its Effect on the Inflammatory, Redox, and Platelet-Activating Factor Enzyme Profile of Apparently Healthy Adults: A Double-Blind Randomized Crossover Trial

  2022cites this paper
• Bioactive Ether Lipids: Primordial Modulators of Cellular Signaling

  2021cites this paper
• Association of PAF and its metabolic enzymes with GGT and the Fatty Liver Index in healthy volunteers.

  2021cites this paper
• Forty Years Since the Structural Elucidation of Platelet-Activating Factor (PAF): Historical, Current, and Future Research Perspectives

  2019cites this paper
• The Anti-inflammatory Properties of Food Polar Lipids

  2019cites this paper
• Inflammation and Cardiovascular Diseases

  2019cites this paper
• Consumption of plant extract supplement reduces platelet activating factor-induced platelet aggregation and increases platelet activating factor catabolism: a randomised, double-blind and placebo-controlled trial

  2019cites this paper
• Inflammation, not Cholesterol, Is a Cause of Chronic Disease

  2018cites this paper
• LncRNA PFL contributes to cardiac fibrosis by acting as a competing endogenous RNA of let-7d

  2018cites this paper
• The Role of Wine in Modulating Inflammatory Processes: A Review

  2018cites this paper
• Postprandial effects of wine consumption on Platelet Activating Factor metabolic enzymes.

  2017cites this paper
• Anagliptin, a dipeptidyl peptidase-4 inhibitor, decreases macrophage infiltration and suppresses atherosclerosis in aortic and coronary arteries in cholesterol-fed rabbits.

  2016cites this paper
• The relation of diet with PAF and its metabolic enzymes in healthy volunteers

  2015cites this paper
• Platelet Activating Factor in Heart Failure: Potential Role in Disease Progression and Novel Target for Therapy

  2013influential citation
• Paricalcitol Effects on Activities and Metabolism of Platelet Activating Factor and on Inflammatory Cytokines in Hemodialysis Patients

  2013cites this paper
• Platelet-activating factor synthesis and receptor-mediated signaling are downregulated in ovine newborn lungs: relevance in postnatal pulmonary adaptation and persistent pulmonary hypertension of the newborn

  2013cites this paper
• Baseline and 6-Week Follow-Up Levels of PAF and Activity of Its Metabolic Enzymes in Patients With Heart Failure and Healthy Volunteers—A Pilot Study

  2013cites this paper
• Interleukin-1beta stimulates platelet-activating factor production in U-937 cells modulating both its biosynthetic and catabolic enzymes.

  2013cites this paper
• Effect of fortified milk on lyso-platelet-activating factor acetyltranferase and lipoprotein-associated phospholipase A2 in hypercholesterolemic adults

  2013cites this paper
• Variation of lipoprotein associated phospholipase A2 across demographic characteristics and cardiovascular risk factors: a systematic review of the literature.

  2012cites this paper
• PAF and its metabolic enzymes in healthy volunteers: interrelations and correlations with basic characteristics.

  2012cites this paper
• Platelet-Activating Factor and Its Basic Metabolic Enzymes in Blood of Naive HIV-Infected Patients

  2012cites this paper
• Platelet activating factor levels and metabolism in tangier disease: a case study

  2012cites this paper
• antioxidantes lipossolúveis com marcadores cardiometabólicos em adolescentes

  2011cites this paper
• Fish polar lipids retard atherosclerosis in rabbits by down-regulating PAF biosynthesis and up-regulating PAF catabolism

  2011cites this paper
• Lipids in Health and Disease Lipoprotein-associated Phospholipase a 2 (lp-pla 2 ) Activity, Platelet-activating Factor Acetylhydrolase (paf-ah) in Leukocytes and Body Composition in Healthy Adults

  2009cites this paper
• Lipids in Health and Disease

  2008cites this paper